Results 241 to 250 of about 402,863 (300)

Versican expression from lung fibroblasts suppresses pulmonary fibrosis. [PDF]

Nat Commun
Kanellopoulou P, Barbayianni I, Fanidis D, Samiotaki M, Katsiouli E, Nastos D, Smyrniotis S, Shira M, Galaris A, Rinotas V, Grammenoudi S, Magkrioti C, Tomos I, Martinez Blanco A, Tremi I, Vamvakaris I, Gavara N, Havaki S, Gorgoulis V, Watanabe H, Aidinis V.   +20 more
europepmc   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Clinical and genetic features of idiopathic pulmonary fibrosis in a Korean cohort. [PDF]

Respir Res
Kim C, Kim SY, Woo A, Shin JH, Sung M, Park MS.   +5 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

TRPML1 suppresses pulmonary fibrosis by limiting collagen and elastin deposition. [PDF]

EMBO J
Weiden EM, Serianz Z, Klingl Y, Jörs S, Jaślan D, Keller M, Castro SP, Mkhitaryan M, Jeridi A, Briukhovetska D, Spix B, Scotto Rosato A, Agami A, Schiller HB, Rajan S, Schredelseker J, Fois G, Frick M, Kobold S, Klein M, Geisler F, Garcia-Fortanet J, Murphy LO, Bracher F, Wahl-Schott C, Gudermann T, Dietrich A, Biel M, Yildirim AÖ, Grimm C.   +29 more
europepmc   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Viral Pathogens and Pulmonary Fibrosis: EMT-Driven Mechanisms and Insights From Traditional Chinese Medicine. [PDF]

Rev Med Virol
Zang N, Wu Y, Li P, Liu Y, Wang S, Leng J, Zhan L, Lyu X, Pang L, Wang J.   +9 more
europepmc   +1 more source

The Role of DLNO in the Functional Assessment of Patients with Idiopathic Pulmonary Fibrosis. [PDF]

Medicina (Kaunas)
Tondo P, Ora J, Natale MP, Scioscia G, Zerillo B, Di Maggio MS, Rogliani P, Lacedonia D.   +7 more
europepmc   +1 more source